Invention Grant
- Patent Title: Inhibition of the survival of pancreatic cancer by cyclohexenone compounds from Antrodia camphorata
- Patent Title (中): 通过樟芝的环己烯酮化合物抑制胰腺癌的存活
-
Application No.: US12832548Application Date: 2010-07-08
-
Publication No.: US08236860B2Publication Date: 2012-08-07
- Inventor: Sheng-Yun Liu , Wu-Che Wen , Mao-Tien Kuo
- Applicant: Sheng-Yun Liu , Wu-Che Wen , Mao-Tien Kuo
- Applicant Address: TW Taipei Hsien
- Assignee: Golden Biotechnology Corporation
- Current Assignee: Golden Biotechnology Corporation
- Current Assignee Address: TW Taipei Hsien
- Agency: Muncy, Geissler, Olds & Lowe, PLLC
- Priority: TW98123264A 20090709
- Main IPC: C07C49/543
- IPC: C07C49/543 ; C07C49/557 ; A61K31/12
Abstract:
The present invention relates to a novel application of a compound. The compound 4--2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of pancreatic cancer cells and be used as a pharmaceutical composition to inhibit the pancreatic tumor growth.
Public/Granted literature
- US20110009494A1 Inhibition of the Survival of Pancreatic Cancer by Cyclohexenone Compounds from Antrodia Camphorata Public/Granted day:2011-01-13
Information query
